DE60128404D1 - Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker - Google Patents

Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker

Info

Publication number
DE60128404D1
DE60128404D1 DE60128404T DE60128404T DE60128404D1 DE 60128404 D1 DE60128404 D1 DE 60128404D1 DE 60128404 T DE60128404 T DE 60128404T DE 60128404 T DE60128404 T DE 60128404T DE 60128404 D1 DE60128404 D1 DE 60128404D1
Authority
DE
Germany
Prior art keywords
prostate
amarkers
devices
quantitative detection
specific membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128404T
Other languages
English (en)
Inventor
George L Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Eastern Virginia Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School
Application granted granted Critical
Publication of DE60128404D1 publication Critical patent/DE60128404D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • G01N33/6851Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
DE60128404T 2000-11-20 2001-11-16 Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker Expired - Lifetime DE60128404D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25245200P 2000-11-20 2000-11-20
PCT/US2001/043424 WO2002046448A2 (en) 2000-11-20 2001-11-16 Methods and devices for the quantitative detection of prostate specific membrane antigen and other prostatic markers

Publications (1)

Publication Number Publication Date
DE60128404D1 true DE60128404D1 (de) 2007-06-21

Family

ID=22956064

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128404T Expired - Lifetime DE60128404D1 (de) 2000-11-20 2001-11-16 Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker

Country Status (9)

Country Link
EP (1) EP1390523B1 (de)
JP (1) JP2004536278A (de)
KR (1) KR20030066672A (de)
CN (1) CN1537170A (de)
AT (1) ATE362107T1 (de)
AU (2) AU4322102A (de)
CA (1) CA2428011A1 (de)
DE (1) DE60128404D1 (de)
WO (1) WO2002046448A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002356844C1 (en) 2001-10-23 2010-03-04 Amgen Fremont Inc. PSMA antibodies and protein multimers
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
GB0305656D0 (en) * 2003-03-12 2003-04-16 Bioinvent Int Ab Screening assay
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP2009532338A (ja) * 2006-03-14 2009-09-10 キャンサー ターゲテッド テクノロジー エルエルシー Psmaのペプチド模倣体阻害剤、それらを含む化合物、およびそれらの使用方法
WO2007129751A1 (ja) * 2006-05-10 2007-11-15 Aska Pharmaceutical Co., Ltd. 前立腺癌と良性前立腺過形成の鑑別法
WO2008021290A2 (en) * 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
CN101158666B (zh) * 2006-10-08 2012-06-27 许洋 一种用含有抗体组的基质去捕获生物样品中生物标志的分析方法
CA2680556A1 (en) 2007-03-12 2008-09-18 Miraculins Inc. Biomarkers of prostate cancer and uses thereof
US9109846B2 (en) 2007-05-07 2015-08-18 Massachusetts Institute Of Technology Polymer sheets and other bodies having oriented chains and method and apparatus for producing same
EP2405022A3 (de) * 2008-07-08 2012-05-02 Genomic Health, Inc. Genexpressionsprofilierung zur Vorhersage der Überlebensfähigkeit von Prostatakrebspatienten
EP2398504B1 (de) * 2009-02-17 2018-11-28 Cornell Research Foundation, Inc. Verfahren und Kits zur Diagnose von Krebs und Vorhersage des therapeutischen Nutzens
JP5222906B2 (ja) * 2010-07-20 2013-06-26 株式会社日立ハイテクノロジーズ 生体試料の分析方法
CN102998448A (zh) * 2011-09-09 2013-03-27 上海市计划生育科学研究所 来源于前列腺分泌液中的前列腺癌标记物
CN102409091A (zh) * 2011-10-17 2012-04-11 刘颜 前列腺分泌蛋白94/57作为卵巢癌、乳腺癌早期临床诊断生物标记物的方法
EA030682B1 (ru) 2012-03-05 2018-09-28 Ой Арктик Партнерс Аб Способы и аппараты для прогнозирования риска рака предстательной железы и объема предстательной железы
JP5429725B1 (ja) * 2013-03-22 2014-02-26 独立行政法人理化学研究所 前立腺癌の進行度の評価方法、前立腺癌の検出方法、および検査キット
EP2806275B1 (de) 2013-05-23 2015-07-01 Bruker Daltonik GmbH Massenspektrometrische Resistenzbestimmung durch Wachstums-Messung
SG10201808585TA (en) 2014-03-28 2018-11-29 Opko Diagnostics Llc Compositions and methods related to diagnosis of prostate cancer
GB2535835B (en) * 2014-12-17 2019-09-04 Micromass Ltd A two-dimensional separation and imaging technique for the rapid analysis of biological samples
DK3253800T3 (da) 2015-03-27 2021-05-31 Opko Diagnostics Llc Prostata antigen standarder og bruge deraf
KR20220078560A (ko) 2019-08-05 2022-06-10 시어 인코퍼레이티드 샘플 제조, 데이터 생성, 및 단백질 코로나 분석을 위한 시스템 및 방법
GB202111635D0 (en) * 2021-08-13 2021-09-29 Randox Laboratories Risk prediction model for prostate cancer
CN114292918A (zh) * 2021-12-31 2022-04-08 刘飞 一种基于LncRNA546标志物的前列腺癌早期诊断方法
CN115711933A (zh) * 2022-11-10 2023-02-24 广东省人民医院 检测试剂、检测试剂盒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334071T2 (de) * 1992-11-05 2007-10-25 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches membranantigen
AU6551398A (en) * 1997-03-11 1998-09-29 Anna C. Ferrari Method of detecting prostate cancer metastasis
WO2000050457A1 (en) * 1999-02-22 2000-08-31 Beckman Coulter, Inc. Prostate-specific membrane antigens and methods of making and using
AU4927501A (en) * 2000-03-20 2001-10-03 Eastern Virginia Med School Prostate cancer markers
US6379550B1 (en) * 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel

Also Published As

Publication number Publication date
EP1390523A4 (de) 2004-03-31
AU2002243221B2 (en) 2006-11-09
CN1537170A (zh) 2004-10-13
ATE362107T1 (de) 2007-06-15
CA2428011A1 (en) 2002-06-13
AU4322102A (en) 2002-06-18
WO2002046448A2 (en) 2002-06-13
EP1390523A2 (de) 2004-02-25
WO2002046448A3 (en) 2003-12-11
EP1390523B1 (de) 2007-05-09
KR20030066672A (ko) 2003-08-09
JP2004536278A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
DE60128404D1 (de) Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker
DE60142254D1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
ATE212674T1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
IL185021A0 (en) Diagnosis method of hepatic steatosis using biochemical markers
WO2004059280A3 (en) Methods, compositions and kits for biomarker extraction
WO2005111243A3 (en) Multiplexed detection of biological agents
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
ATE462492T1 (de) Vorrichtung zur detektion von targetmolekülen
NO20025371L (no) Forbedringer til fluorescense polymer-QTL tiln¶rming til biodetektering
ATE219151T1 (de) Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
GB2431988A (en) Assay device & method
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DK0975800T3 (da) Analyse af nukleotider i opløsning under anvendelse af PNA-prober
DE60031204D1 (de) VERFAHREN und KIT ZUM NACHWEIS UND ZUR IDENTIFIZIERUNG VON KRISTALLEN IN BIOLOGISCHEN FLÜSSIGKEITEN
BRPI0414283A (pt) métodos, composições e kits para a concentração e detecção de microorganismos
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
DE69837155D1 (de) Verfahren zum nachweiss von antikörpern in einer probe
ATE272718T1 (de) Verfahren zur bestimmung von disaccharidasen
DE50110172D1 (de) Verfahren zur altersbestimmung von individuen
ATE292283T1 (de) Verfahren zur immobilisierung von affinen reagentien an hydrophoben festphasen
PT1218749E (pt) Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre
DK1664330T3 (da) Blod- og urintest
DK1192469T3 (da) Assay
DK1297342T3 (da) Metode til diagnostisk bestemmelse af Alzheimer's sygdom på basis af holo-transcobalamin II

Legal Events

Date Code Title Description
8332 No legal effect for de